474 results on '"Deraco M"'
Search Results
2. Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases
3. External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification
4. Validation of a Nomogram to Predict Recurrence in Patients with Mucinous Neoplasms of the Appendix with Peritoneal Dissemination After Cytoreductive Surgery and HIPEC
5. Preliminary results of a program for the implementation of laparoscopic colorectal surgery in an Italian comprehensive cancer center during the COVID-19 pandemic
6. ASO Author Reflections: Management of Recurrent Pseudomyxoma Peritonei After Cytoreductive Surgery and HIPEC
7. The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma
8. Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment
9. Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up
10. ASO Visual Abstract: Validation of a Nomogram to Predict Recurrence in Patients with Mucinous Neoplasms of the Appendix with Peritoneal Dissemination after Cytoreductive Surgery and HIPEC
11. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)
12. External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification
13. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Methodology
14. ASO Author Reflections: Management of Recurrent Pseudomyxoma Peritonei After Cytoreductive Surgery and HIPEC
15. Figure 6 from: Babot MJ, Rougier GW, García-López DA, Bertelli SB, Herrera CM, Deraco MV, Giannini NP (2022) New mandibular remains of Callistoe (Metatheria, Sparassodonta) reveal unexpected anatomical, functional, and evolutionary aspects of this carnivorous genus. Vertebrate Zoology 72: 469-485. https://doi.org/10.3897/vz.72.e82709
16. Figure 1 from: Babot MJ, Rougier GW, García-López DA, Bertelli SB, Herrera CM, Deraco MV, Giannini NP (2022) New mandibular remains of Callistoe (Metatheria, Sparassodonta) reveal unexpected anatomical, functional, and evolutionary aspects of this carnivorous genus. Vertebrate Zoology 72: 469-485. https://doi.org/10.3897/vz.72.e82709
17. Figure 4 from: Babot MJ, Rougier GW, García-López DA, Bertelli SB, Herrera CM, Deraco MV, Giannini NP (2022) New mandibular remains of Callistoe (Metatheria, Sparassodonta) reveal unexpected anatomical, functional, and evolutionary aspects of this carnivorous genus. Vertebrate Zoology 72: 469-485. https://doi.org/10.3897/vz.72.e82709
18. Figure 5 from: Babot MJ, Rougier GW, García-López DA, Bertelli SB, Herrera CM, Deraco MV, Giannini NP (2022) New mandibular remains of Callistoe (Metatheria, Sparassodonta) reveal unexpected anatomical, functional, and evolutionary aspects of this carnivorous genus. Vertebrate Zoology 72: 469-485. https://doi.org/10.3897/vz.72.e82709
19. New mandibular remains of Callistoe (Metatheria, Sparassodonta) reveal unexpected anatomical, functional, and evolutionary aspects of this carnivorous genus
20. Figure 2 from: Babot MJ, Rougier GW, García-López DA, Bertelli SB, Herrera CM, Deraco MV, Giannini NP (2022) New mandibular remains of Callistoe (Metatheria, Sparassodonta) reveal unexpected anatomical, functional, and evolutionary aspects of this carnivorous genus. Vertebrate Zoology 72: 469-485. https://doi.org/10.3897/vz.72.e82709
21. Figure 3 from: Babot MJ, Rougier GW, García-López DA, Bertelli SB, Herrera CM, Deraco MV, Giannini NP (2022) New mandibular remains of Callistoe (Metatheria, Sparassodonta) reveal unexpected anatomical, functional, and evolutionary aspects of this carnivorous genus. Vertebrate Zoology 72: 469-485. https://doi.org/10.3897/vz.72.e82709
22. ASO Visual Abstract: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
23. Correction: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (Annals of Surgical Oncology, (2021), 10.1245/s10434-021-11045-3)
24. Correction: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (Annals of Surgical Oncology, (2022), 29, 6, (3405-3417), 10.1245/s10434-021-11045-3)
25. HIPEC Methodology and Regimens: The Need for an Expert Consensus
26. Peritoneal Mesothelioma: PSOGI/EURACAN Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up
27. Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O.
28. Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer
29. Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
30. Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
31. AIOM recommendations on the use of cytoreductive surgery and HIPEC in primary and secondary peritoneal tumors
32. Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei: Estudio multicéntrico de la curva de aprendizaje y la realización del procedimiento quirúrgico en la cirugía citorreductora con quimioterapia intraperitoneal para el pseudomixoma peritoneal
33. Appendiceal Tumours and Pseudomyxoma Peritonei: Literature Review with PSOGI/EURACAN Clinical Practice Guidelines for Diagnosis and Treatment
34. The delphi and GRADE methodology used in the PSOGI 2018 consensus statement on pseudomyxoma peritonei and peritoneal mesothelioma
35. The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma.
36. Diffuse Malignant Peritoneal Mesothelioma: Failure Analysis Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
37. Multicystic and Well-differentiated Papillary Peritoneal Mesothelioma Treated by Surgical Cytoreduction and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)
38. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement
39. Past, present and future of adjuvant HIPEC in patients at high risk for colorectal peritoneal metastases
40. Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment
41. The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma
42. Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up
43. Colorectal peritoneal metastases treated by perioperative systemic chemotherapy and cytoreductive surgery with or without HIPEC. A comparative study using the Peritoneal Surface Disease Severity Score (PSDSS)
44. Impact of “ovarian staging” on operative and long-term outcomes in females affected by primary peritoneal surface malignancies requiring CRS and HIPEC: Final results
45. Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan
46. Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study
47. Importance of gender in diffuse malignant peritoneal mesothelioma
48. Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma
49. 1st Evidence-based Italian consensus conference on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from ovarian cancer
50. CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.